246 related articles for article (PubMed ID: 12508639)
1. [Combination therapy of experimental murine hepatoma with mIL-12 gene and MHC I gene mediated by liposome].
Wang KM; Xia AD; Chen SS
Ai Zheng; 2002 Oct; 21(10):1041-6. PubMed ID: 12508639
[TBL] [Abstract][Full Text] [Related]
2. [Combination therapy of murine liver cancer with IL-12 gene and HSV-TK gene].
Tang Z; Sun W; Chen S
Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):332-5. PubMed ID: 11776567
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
4. [Experimental gene therapy mediated by fractalkine (FK) for murine liver cancer].
Tang L; Hu P; Hu HD; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):675-7. PubMed ID: 16174457
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of antitumor immunity against B16 melanoma tumor using genetically modified dendritic cells to produce cytokines.
Akiyama Y; Watanabe M; Maruyama K; Ruscetti FW; Wiltrout RH; Yamaguchi K
Gene Ther; 2000 Dec; 7(24):2113-21. PubMed ID: 11223993
[TBL] [Abstract][Full Text] [Related]
6. [Combined gene therapy for murine liver cancer with interleukin-18 and cytosine deaminase genes].
Sun W; Tang Z; Wei D; Tang Y; Chen S
Zhonghua Gan Zang Bing Za Zhi; 2001 Oct; 9(5):300-2. PubMed ID: 11676879
[TBL] [Abstract][Full Text] [Related]
7. The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.
Douin-Echinard V; Bornes S; Rochaix P; Tilkin AF; Peron JM; Bonnet J; Favre G; Couderc B
Cancer Gene Ther; 2000 Dec; 7(12):1543-56. PubMed ID: 11228533
[TBL] [Abstract][Full Text] [Related]
8. IL-12 cDNA direct injection: antimetastatic effect from a single injection in a murine hepatic metastases model.
Weber SM; Qi C; Neal Z; Sondel P; Mahvi DM
J Surg Res; 2004 Dec; 122(2):210-7. PubMed ID: 15555620
[TBL] [Abstract][Full Text] [Related]
9. [Nanoparticle-mediated endostatin gene therapy targeting hepatocellular carcinoma utilizing heat-inducible promoter].
Zhou JJ; Chen RF; Li ZH; Zhou QB; Tang QB; He XY; Lu HW; Guo N
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):795-9. PubMed ID: 19595115
[TBL] [Abstract][Full Text] [Related]
10. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
Wu Q; Mahendran R; Esuvaranathan K
Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
[TBL] [Abstract][Full Text] [Related]
11. Effective gene transfer to solid tumors using different nonviral gene delivery techniques: electroporation, liposomes, and integrin-targeted vector.
Cemazar M; Sersa G; Wilson J; Tozer GM; Hart SL; Grosel A; Dachs GU
Cancer Gene Ther; 2002 Apr; 9(4):399-406. PubMed ID: 11960291
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
13. [Human antisense-vascular endothelial growth factor gene therapy for laryngeal tumor by cationic liposome-mediated transfection].
Deng ZH; Jin M; Huang WG; Qiu JH; Liu SL; Wang JL
Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):8-12. PubMed ID: 15127560
[TBL] [Abstract][Full Text] [Related]
14. [Gene transfection of endostatin synergizes with doxorubicin to suppress human hepatocellular carcinomas: experiment with mice].
Liu FJ; Tan G; Li J; Sun XY
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(30):2147-51. PubMed ID: 19080480
[TBL] [Abstract][Full Text] [Related]
15. Fusogenic activity of vesicular stomatitis virus glycoprotein plasmid in tumors as an enhancer of IL-12 gene therapy.
Eslahi NK; Muller S; Nguyen L; Wilson E; Thull N; Rolland A; Pericle F
Cancer Gene Ther; 2001 Jan; 8(1):55-62. PubMed ID: 11219494
[TBL] [Abstract][Full Text] [Related]
16. Adenoviral transfer of xenogeneic MHC class I gene results in loss of tumorigenicity and inhibition of tumor growth.
Campbell I; Moyana T; Carlsen S; Zheng C; Xiang J
Cancer Gene Ther; 2000 Jan; 7(1):37-44. PubMed ID: 10678354
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of E7 antisense RNA-induced antitumor immunity by co-delivery of IL-12 gene in HPV16 DNA-positive mouse tumor.
He YK; Lui VW; Baar J; Wang L; Shurin M; Almonte C; Watkins SC; Huang L
Gene Ther; 1998 Nov; 5(11):1462-71. PubMed ID: 9930299
[TBL] [Abstract][Full Text] [Related]
18. [Establishment of AFP promoter operated murine IL-1beta recombinant vector and its expression in H22 cells].
Li QC; Liang SJ; Wang XJ; Liu YY; Wang HQ; Zhang SH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):603-5. PubMed ID: 19737477
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection.
Liu X; Tian P; Yu Y; Yao M; Cao X; Gu J
Cancer Gene Ther; 2002 Jan; 9(1):100-8. PubMed ID: 11916239
[TBL] [Abstract][Full Text] [Related]
20. [Oral gene therapy via live attenuated Salmonella leads to tumor regression and survival prolongation in mice].
Qi H; Li YH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1738-41. PubMed ID: 17259109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]